Bryce Richard Paul

See Remarks | Sr VP, Clinical Research &Dev

1 company

Bryce Richard Paul is a See Remarks at PUMA BIOTECHNOLOGY, INC.. Recent SEC Form 4 filings include 0 buys and 10 sells.

Estimated insider holdings value: $964K based on current market prices.

Holdings by Company

PBYIApr 5, 2021

Current Shares121.7K

Value$963.6K

Net Activity-62,888

Bought: 0Sold: 62.9K

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Apr 5, 2021	PBYI Puma Biotechnology, Inc.	See Remarks	Sell	426	$9.80	$4,176.04	-0.3%	-12.7%	-66.9%
Mar 2, 2021	PBYI Puma Biotechnology, Inc.	See Remarks	Sell	422	$10.15	$4,283.30	-0.3%	-	-
Feb 2, 2021	PBYI Puma Biotechnology, Inc.	See Remarks	Sell	415	$12.23	$5,075.95	-0.6%	-	-
Jan 4, 2021	PBYI Puma Biotechnology, Inc.	See Remarks	Sell	6,548	$10.23	$67,016.16	-8.5%	-	-
Dec 2, 2020	PBYI Puma Biotechnology, Inc.	See Remarks	Sell	92	$11.65	$1,071.80	-0.1%	-	-
Nov 2, 2020	PBYI Puma Biotechnology, Inc.	See Remarks	Sell	97	$7.81	$757.57	-0.1%	-	-
Oct 2, 2020	PBYI Puma Biotechnology, Inc.	See Remarks	Sell	91	$10.14	$923.10	-0.1%	-	-
Sep 2, 2020	PBYI Puma Biotechnology, Inc.	See Remarks	Sell	90	$9.77	$879.30	-0.1%	-	-
Aug 3, 2020	PBYI Puma Biotechnology, Inc.	See Remarks	Sell	86	$10.80	$928.80	-0.1%	-	-
Jul 2, 2020	PBYI Puma Biotechnology, Inc.	See Remarks	Sell	660	$10.67	$7,040.42	-0.8%	-	-